期刊文献+
共找到641篇文章
< 1 2 33 >
每页显示 20 50 100
5-Fluorouracil-loaded Self-assembled pH-sensitive Nanoparticles as Novel Drug Carrier for Treatment of Malignant Tumors 被引量:7
1
作者 刘亮 晋平 +2 位作者 程明 张国亮 张凤宝 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2006年第3期377-382,共6页
In order to improve the cancer-targeting and selective activity of antineoplastic agent [5-fluorouracil (5-FU)], a novel pH-responsive drug delivery system [pullulan acetate/sulfonamide (PA/SDM) conjugate] was syn... In order to improve the cancer-targeting and selective activity of antineoplastic agent [5-fluorouracil (5-FU)], a novel pH-responsive drug delivery system [pullulan acetate/sulfonamide (PA/SDM) conjugate] was synthesized by a diafiltration method. Sulfonamide was grafted to the hydrophobicaUy modified pullulan acetate to enhance the pH sensitivity for better cancer-targeting delivery. 5-FU was loaded into the self-assembled nanoparticles by the same method. The drug-loaded self-assembled nanoparticles were successfully obtained and characterized in terms of particle size, morphology and drug loading and release profile at various pHs. The results showed that the mean diameter of the self-assembled particles was approximately 100nm, with uniform size and good spherical morphology. The nanoparticles showed good stability at pH 7.4, which is equal to that of the normal body fluid, but shrank and aggregated below pH 6.8, which is close to the pH with tumors. The loading efficiency and concentration of released 5-FU was monitored at 269 nm on the UVNis spectrophotometer. The release profile was heavily pH-dependent around phvsiological pH, and the release rate was significantly enhanced under pH of 6.8. 展开更多
关键词 5-FLUOROURACIL self-assembled nanoparticles pH sensitivity drug delivery PULLULAN
下载PDF
5-Fluorouracil-loaded Self-assembled pH-sensitive Nanoparticles as Novel Drug Carrier for Treatment of Malignant Tumors 被引量:1
2
作者 刘亮 晋平 +2 位作者 程明 张国亮 张凤宝 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2006年第3X期377-382,共6页
In order to improve the cancer-targeting and selective activity of antineoplastic agent [5-fluorouracil (5-FU)], a novel pH-responsive drug delivery system [pullulan acetate/sulfonamide (PA/SDM) conjugate] was syn- th... In order to improve the cancer-targeting and selective activity of antineoplastic agent [5-fluorouracil (5-FU)], a novel pH-responsive drug delivery system [pullulan acetate/sulfonamide (PA/SDM) conjugate] was syn- thesized by a diafiltration method. Sulfonamide was grafted to the hydrophobically modified pullulan acetate to enhance the pH sensitivity for better cancer-targeting delivery. 5-FU was loaded into the self-assembled nanoparti- cles by the same method. The drug-loaded self-assembled nanoparticles were successfully obtained and character- ized in terms of particle size, morphology and drug loading and release profile at various pHs. The results showed that the mean diameter of the self-assembled particles was approximately 100nm, with uniform size and good spherical morphology. The nanoparticles showed good stability at pH 7.4, which is equal to that of the normal body fluid, but shrank and aggregated below pH 6.8, which is close to the pH with tumors. The loading efficiency and concentration of released 5-FU was monitored at 269 nm on the UV/Vis spectrophotometer. The release profile was heavily pH-dependent around physiological pH, and the release rate was significantly enhanced under pH of 6.8. 展开更多
关键词 5-FLUOROURACIL SELF-ASSEMBLED NANOPARTICLES pH sensitivity drug delivery PULLULAN
下载PDF
Anticancer Drugs (V)─—Synthesis of Etoposide Derivatives 被引量:1
3
作者 TIAN Xuan YAN Ze-qun LI Jin-xin and CHEN Yao-zu(National Laboratory of Applied Organic Chemistry,Lanzhou Uniuersty, Lanzhou , 730000)MU Xiao-qin(Department of Chemistry , Tianshui Teaches’ College , Tianshui , 741000) 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 1995年第1期79-83,共5页
AnticancerDrugs(V)─—SynthesisofEtoposideDerivativesTIANXuan,YANZe-qun,LIJin-xinandCHENYao-zu(NationalLaborat... AnticancerDrugs(V)─—SynthesisofEtoposideDerivativesTIANXuan,YANZe-qun,LIJin-xinandCHENYao-zu(NationalLaboratoryofAppliedOrgan... 展开更多
关键词 ETOPOSIDE Anticancer drugs Nitroxyl radical 5-FLUOROURACIL
下载PDF
5-Fluorouracil Loaded Chitosan–PVA/Na^+MMT Nanocomposite Films for Drug Release and Antimicrobial Activity 被引量:1
4
作者 A.Babul Reddy B.Manjula +3 位作者 T.Jayaramudu E.R.Sadiku P.Anand Babu S.Periyar Selvam 《Nano-Micro Letters》 SCIE EI CAS 2016年第3期260-269,共10页
In the present study, chitosan and polyvinyl alcohol(PVA) were blended with different concentrations of sodium montmorillonite(Na^+MMT) clay solution by a solvent casting method. X-ray diffraction and transition elect... In the present study, chitosan and polyvinyl alcohol(PVA) were blended with different concentrations of sodium montmorillonite(Na^+MMT) clay solution by a solvent casting method. X-ray diffraction and transition electron microscope results show that the film properties are related to the co-existence of Na^+MMT intercalation/exfoliation in the blend and the interaction between chitosan–PVA and Na^+MMT. 5-Fluorouracil(5-FU) was loaded with chitosan–PVA/Na^+MMT nanocomposite films for in vitro drug delivery study. The antimicrobial activity of the chitosan–PVA/Na^+MMT films showed significant effect against Salmonella(Gram-negative) and Staphylococcus aureus(Gram-positive), whereas5-FU encapsulated chitosan–PVA/Na^+MMT bio-nanocomposite films did not show any inhibition against bacteria. Our results indicate that combination of a flexible and soft polymeric material with high drug loading ability of a hard inorganic porous material can produce improved control over degradation and drug release. It will be an economically viable method for preparation of advanced drug delivery vehicles and biodegradable implants or scaffolds. 展开更多
关键词 BIOPOLYMER Chitosan–PVA/Na+MMT MONTMORILLONITE 5-FLUOROURACIL drug release Antimicrobial activity
下载PDF
Preparation and drug releasing property of magnetic chitosan-5-fluorouracil nano-particles 被引量:3
5
作者 王东生 李建国 +1 位作者 李和平 唐发清 《中国有色金属学会会刊:英文版》 EI CSCD 2009年第5期1232-1236,共5页
In order to synthesize the targeting drug carrier system,magnetic chitosan-5-fluorouracil nano-particles were prepared by using 5-fluorouracil(5-Fu)as model drug,Fe3O4 nano-particles as kernel,chitosan as enveloping m... In order to synthesize the targeting drug carrier system,magnetic chitosan-5-fluorouracil nano-particles were prepared by using 5-fluorouracil(5-Fu)as model drug,Fe3O4 nano-particles as kernel,chitosan as enveloping material and glutaraldehyde as cross linking agent through ultrasonic technique.The morphology of the magnetic chitosan-5-Fu nano-particles was observed with a transmission electron microscope(TEM).The results showed that magnetic chitosan-5-Fu nano-particles were prepared in spherical structure with a size range of 50-60 nm.The delivering capacity and drug releasing properties of magnetic chitosan-5-Fu nano-particles were investigated by UV-vis spectrum analysis.The results showed that the loading capacity was 13.4%and the cumulative release percentage in the phosphate buffer(pH=7.2)solutions was 68%in 30 h.These data indicate that the wrapped drug of magnetic chitosan-5-Fu nano-particles was slowly-released.The magnetic response of magnetic chitosan-5-Fu nano-particles was studied by UV-vis spectrometer to detect the changes of solution absorbance.Without external magnetic field,the nano-particle deposition rate was slow.When being subjected to 8 mT magnetic field,the particle sedimentation rate was increased rapidly.The results showed that magnetic chitosan-5-Fu nano-particles have a magnetic stability and strong targeting characteristics. 展开更多
关键词 FE3O4纳米粒子 磁性壳聚糖 药物释放 氟尿嘧啶 制备 透射电子显微镜 财产 紫外可见光谱
下载PDF
Recent advances regarding the role of ABC subfamily C member 10(ABCC10) in the efflux of antitumor drugs 被引量:3
6
作者 Rishil J.Kathawala Yi-Jun Wang +1 位作者 Charles R.Ashby Jr Zhe-Sheng Chen 《Chinese Journal of Cancer》 SCIE CAS CSCD 2014年第5期223-230,共8页
ABCC10,also known as multidrug-resistant protein 7(MRP7),is the tenth member of the C subfamily of the ATP-binding cassette(ABC) superfamily.ABCC10 mediates multidrug resistance(MDR) in cancer cells by preventing the ... ABCC10,also known as multidrug-resistant protein 7(MRP7),is the tenth member of the C subfamily of the ATP-binding cassette(ABC) superfamily.ABCC10 mediates multidrug resistance(MDR) in cancer cells by preventing the intracellular accumulation of certain antitumor drugs.The ABCC10 transporter is a 171-kDa protein that is localized on the basolateral cell membrane.ABCC10 is a broad-specificity transporter of xenobiotics,including antitumor drugs,such as taxanes,epothilone B,vinca alkaloids,and cytarabine,as well as modulators of the estrogen pathway,such as tamoxifen.In recent years,ABCC10 inhibitors,including cepharanthine,lapatinib,erlotinib,nilotinib,imatinib,sildenafil,and vardenafil,have been reported to overcome ABCC10-mediated MDR.This review discusses some recent and clinically relevant aspects of the ABCC10 drug efflux transporter from the perspective of current chemotherapy,particularly its inhibition by tyrosine kinase inhibitors and phosphodiesterase type 5 inhibitors. 展开更多
关键词 抗肿瘤药物 家族 酪氨酸激酶抑制剂 外排 多药耐药 磷酸二酯酶 转运体 埃坡霉素
下载PDF
The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models
7
作者 SITONG QIAN YING FANG +11 位作者 CHENGYUN YAO YONGSHENG WANG ZHI ZHANG XIAOHUA WANG JIN GAO YONG FENG LEI SUN RUNYUE ZOU GUOREN ZHOU JINJUN YE RUIXUE XIA HONGPING XIA 《Oncology Research》 SCIE 2022年第2期53-64,共12页
Previous studies have shown that PRDX5 and Nrf2 are antioxidant proteins related to abnormal reactive oxidative species(ROS).PRDX5 and Nrf2 play a critical role in the progression of inflammations and tumors.The combin... Previous studies have shown that PRDX5 and Nrf2 are antioxidant proteins related to abnormal reactive oxidative species(ROS).PRDX5 and Nrf2 play a critical role in the progression of inflammations and tumors.The combination of PRDX5 and Nrf2 was examined by Co-immunoprecipitation,western blotting and Immunohistochemistry.H2O2 was applied to affect the production of ROS and induced multi-resistant protein 1(MRP1)expression in NSCLC cells.The zebrafish models mainly investigated the synergistic effects of PRDX5 and Nrf2 on lung cancer drug resistance under oxidative stress.We showed that PRDX5 and Nrf2 form a complex and significantly increase the NSCLC tissues compared to adjacent tissues.The oxidative stress improved the combination of PRDX5 and Nrf2.We demonstrated that the synergy between PRDX5 and Nrf2 is positively related to the proliferation and drug resistance of NSCLC cells in the zebrafish models.In conclusion,our data indicated that PRDX5 could bind to Nrf2 and has a synergistic effect with Nrf2.Meanwhile,in the zebrafish models,PRDX5 and Nrf2 have significant regulatory impacts on lung cancer progression and drug resistance activities under oxidative stress. 展开更多
关键词 PRDX5 NRF2 Oxidative stress Lung cancer drug resistance Zebrafish models
下载PDF
SETD5介导AKT1磷酸化调控结肠癌细胞的迁移和5-FU敏感性
8
作者 黄开禹 史建国 程勇 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2024年第6期586-591,共6页
目的:探讨含SET结构域蛋白5(SETD5)对结肠癌细胞增殖、迁移和对5-氟尿嘧啶(5-FU)药物敏感性的影响及机制。方法:常规培养结肠癌细胞,用Lipofectamine 2000将siSETD5-NC、si-SETD5-1~3质粒转染至HT-29细胞中,将其分为对照组(未处理)、si-... 目的:探讨含SET结构域蛋白5(SETD5)对结肠癌细胞增殖、迁移和对5-氟尿嘧啶(5-FU)药物敏感性的影响及机制。方法:常规培养结肠癌细胞,用Lipofectamine 2000将siSETD5-NC、si-SETD5-1~3质粒转染至HT-29细胞中,将其分为对照组(未处理)、si-SETD5-NC组、si-SETD5组和si-SETD5+SC79组,si-SETD5+SC79组HT-29细胞转染质粒的同时用10µmol/L SC79处理。qPCR法检测NCM460、HT-29和LoVo细胞中SETD5 mRNA表达,流式细胞术、细胞划痕法、WB法和CCK-8法分别检测各组HT-29细胞的凋亡情况、迁移能力、相关蛋白的表达,以及对5-FU的敏感性。结果:SETD5 mRNA在HT-29、LoVo细胞中均呈高表达(均P<0.01)。在HT-29细胞中成功地敲减了SETD5 mRNA(P<0.01)。敲减SETD5 mRNA可明显抑制HT-29细胞的增殖活性(P<0.01)、迁移能力(P<0.01)、相关蛋白(SETD5、p-PI3K、p-AKT1、p-mTOR蛋白)的表达(均P<0.01)、促进细胞凋亡(P<0.01),且提高其对5-FU的敏感性(P<0.01),这些作用均可被AKT激活剂SC79部分阻挡(P<0.05或P<0.01)。结论:SETD5在HT-29、LoVo细胞中高表达,SETD5通过PI3K/AKT1通路促进结肠癌HT-29细胞的增殖、迁移,且降低其对5-FU的敏感性,SETD5是结肠癌临床诊断、治疗的潜在靶点。 展开更多
关键词 结肠癌 含有SET结构域蛋白5 蛋白激酶B磷酸化 增殖 迁移 5-氟尿嘧啶 耐药
下载PDF
5-HT_(2A)受体拮抗剂治疗神经精神疾病幻觉症状研究进展
9
作者 赵玉 陈爱兵 +1 位作者 俞纲 苏瑞斌 《中国药理学与毒理学杂志》 CAS 北大核心 2024年第5期384-391,共8页
帕金森病、阿尔茨海默病和精神分裂症等神经精神疾病在发展过程中会出现幻觉、妄想等精神病症状,这些症状发病率高、治愈难,严重影响患者生活质量。尽管经典抗精神病药物氯丙嗪、舒必利和奋乃静等通过拮抗多巴胺2型(D_(2))受体可治疗相... 帕金森病、阿尔茨海默病和精神分裂症等神经精神疾病在发展过程中会出现幻觉、妄想等精神病症状,这些症状发病率高、治愈难,严重影响患者生活质量。尽管经典抗精神病药物氯丙嗪、舒必利和奋乃静等通过拮抗多巴胺2型(D_(2))受体可治疗相关症状,但也会引发不可控的锥体外系反应和高泌乳素症等不良反应。近年来研究发现,奥氮平、氯氮平、利培酮和匹莫范色林等非经典抗精神病药物通过拮抗5-羟色胺2A(5-HT_(2A))受体或同时拮抗5-HT_(2A)受体(强)和D_(2)受体(弱)治疗神经精神疾病的幻觉症状。非临床研究结果表明,在多种因素诱导的幻觉模型上,非经典抗精神病药物均表现出良好的治疗作用;临床研究进一步证实,该类药物显著改善精神病症状(以幻觉和妄想为主),尤其是匹莫范色林,其对氯氮平、利培酮不敏感或耐受的患者仍能表现出良好的治疗效果。同时,非经典抗精神病药物不良反应的发生率和严重程度较低,总体耐受性较好。本文综述了5-HT_(2A)受体拮抗剂改善神经精神疾病伴随的幻觉症状的研究进展,为设计开发新型神经精神疾病治疗药物提供参考。 展开更多
关键词 5-HT_(2A)受体 拟精神病药物 拮抗剂 幻觉
下载PDF
5-氨基水杨酸口服制剂及联合中药在炎症性肠病治疗中的应用
10
作者 程燕 颜冬梅 +1 位作者 李飞 朱卫丰 《中国现代中药》 CAS 2024年第8期1420-1431,共12页
5-氨基水杨酸(5-ASA)是1种从中药柳树皮中分离提纯得到的天然抗炎活性成分水杨酸的衍生物,别名阿米诺水杨酸、美沙拉嗪,是临床治疗炎症性肠病(IBD)并预防其复发的一线药物。尽管目前莎尔福(Salofalk)、亚沙可(Asacol)和潘他沙(Pentasa)... 5-氨基水杨酸(5-ASA)是1种从中药柳树皮中分离提纯得到的天然抗炎活性成分水杨酸的衍生物,别名阿米诺水杨酸、美沙拉嗪,是临床治疗炎症性肠病(IBD)并预防其复发的一线药物。尽管目前莎尔福(Salofalk)、亚沙可(Asacol)和潘他沙(Pentasa)等5-ASA口服结肠靶向制剂已广泛用于IBD的临床治疗,但仍存在在小肠提前释药和受胃肠道生理状态影响显著等制剂缺陷、对克罗恩病和重度溃疡性结肠炎(UC)治疗效果不佳等临床未满足的需求,以及减少UC患者黏膜菌群多样性、长期使用增加用药风险和降低患者服药依从性等问题。开发硅胶纳米粒、水凝胶等新型递药载体,基于pH依赖、时滞控制和菌群/酶触发等多机制结合释药原理设计新型口服结肠靶向制剂从而解决制剂缺陷问题,提高5-ASA疗效和患者服药耐受性、依从性是目前制剂研究的重点。此外,5-ASA口服制剂联合中药保留灌肠、中药口服制剂和注射液等治疗IBD可发挥协同抗炎作用,实现增效减毒目的。对5-ASA口服制剂品种、近年来新型制剂和递药载体的研究进展,以及与中药联用的临床应用和研究现状等进行综述,为5-ASA口服制剂的剂型改造、载体材料研究和临床用药等提供参考。 展开更多
关键词 5-氨基水杨酸 口服结肠靶向制剂 递药载体 联合中药 炎症性肠病
下载PDF
一步/分步载药法对LDH/5-FU的粒径及形貌影响
11
作者 李雪 王怡轩 张瑞平 《广州化工》 CAS 2024年第5期61-63,共3页
层状双氢氧化物(LDH)是一种带正电性的无机层状载体,其用于负载电负性的药物可实现药物的缓控释。使用了一步载药法及分步载药法将带负电的药物5-氟尿嘧啶(5-FU)负载于LDH层间,合成了药物递送系统LDH/5-FU。通过不同的载药方法得到了LDH... 层状双氢氧化物(LDH)是一种带正电性的无机层状载体,其用于负载电负性的药物可实现药物的缓控释。使用了一步载药法及分步载药法将带负电的药物5-氟尿嘧啶(5-FU)负载于LDH层间,合成了药物递送系统LDH/5-FU。通过不同的载药方法得到了LDH/5-FU,拍摄了其透射电镜图,并观察了其粒径分布。结果表明,一步载药法合成的LDH/5-FU粒径在2 000 nm左右,PDI较大,分布不均匀,易团聚;分步载药法合成的LDH/5-FU粒径在200 nm左右,PDI相对较小,分布更为均匀。 展开更多
关键词 层状双氢氧化物 5-氟尿嘧啶 药物负载 LDH/5-FU
下载PDF
Release of Anticancer Drug 5-Fluorouracil from Different Ionically Crosslinked Alginate Beads
12
作者 Merve Olukman Oya Sanli Ebru Kondolot Solak 《Journal of Biomaterials and Nanobiotechnology》 2012年第4期469-479,共11页
In this research;the release of 5-Fluorouracil (5-FU) from different ionically crosslinked alginate (Alg) beads was investigated by using Fe3+, Al3+, Zn2+, and Ca2+, ions as crosslinking agent. The prepared beads were... In this research;the release of 5-Fluorouracil (5-FU) from different ionically crosslinked alginate (Alg) beads was investigated by using Fe3+, Al3+, Zn2+, and Ca2+, ions as crosslinking agent. The prepared beads were characterized by Fourier Transform Infrared Spectroscopy (FTIR) Differential Scanning Calorimetry (DSC) and Scanning Electron Micros-copy (SEM). The drug release studies were carried out at three pH values 1.2, 6.8 and 7.4 respectively each for two hours. The effects of the preparation conditions as crosslinker type, drug/polymer (w/w) ratio, crosslinker concentration and time of exposure to crosslinker on the release of 5-FU were investigated for 6 hours at 37℃. It was observed that 5-FU release from the beads followed the order of Fe > Zn > Al > Ca-Alg and increased with increasing drug/polymer ratio. At the end of 6 hours, the highest 5-FU release was found to be 90% (w/w) for Fe-Alg beads at the drug/polymer ratio of 1/8 (w/w), crosslinker concentration of 0.05 M, exposure time of 10 minutes respectively. The swelling measurements of the beads supported the release results. Release kinetics was described by Fickian and non-Fickian approaches. 展开更多
关键词 Anticancer drug pH Responsive Release ALGINATE Ionically Crosslinking Controlled Release 5-FLUOROURACIL
下载PDF
Influences of Organic Solvents on Particle Size and Drug-loading Efficiency for 5-Fluorouracil Poly(lactic acid)Nanoparticles
13
作者 LIUXiao-yan CHANGJin +4 位作者 GUOYan-shuang YUANXu-bo LIXiao-rong LIUChun-ling SONGCun-xian 《Chinese Journal of Biomedical Engineering(English Edition)》 2004年第2期52-58,共7页
The objective of this study was to investigate the influences of organic solvents on particle size, drug content, loading efficiency and yield for 5 Fluorouracil Poly(lactic acid) nanoparticles . The 5 Fluorouracil wa... The objective of this study was to investigate the influences of organic solvents on particle size, drug content, loading efficiency and yield for 5 Fluorouracil Poly(lactic acid) nanoparticles . The 5 Fluorouracil was entrapped into poly(lactic acid)(PLA) nanoparticles using a water in oil in water solvent evaporation technique. During the preparation process, ethyl acetate and acetone were used as organic solvents since they are less toxic than the more commonly used dichloromethane. The effect of the three solvents on particle size, drug content, loading efficiency and yield of nanopartcles was compared. When the solvent of the oil phase was acetone, the highest drug content, smallest particle size and lowest yield were obtained for the PLA nanoparticles. 展开更多
关键词 NANOPARTICLES Poly(lactic acid) 5-FLUOROURACIL Particle size drug content
下载PDF
敲减MET表达对喉癌Hep-2细胞增殖、迁移及5-FU和顺铂敏感性的影响
14
作者 张翠红 肖淑芬 +3 位作者 张建军 贺占国 范才 马博敬 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2024年第9期857-863,共7页
目的:探究敲减间质表皮转化因子(MET)表达对人喉鳞状细胞癌(LSCC)Hep-2细胞生长、迁移及5-氟尿嘧啶(5-FU)和顺铂敏感性的影响。方法:通过基因表达综合数据库(GEO)及癌症基因组图谱(TCGA)数据库数据分析人LSCC组织中MET mRNA的表达水平;... 目的:探究敲减间质表皮转化因子(MET)表达对人喉鳞状细胞癌(LSCC)Hep-2细胞生长、迁移及5-氟尿嘧啶(5-FU)和顺铂敏感性的影响。方法:通过基因表达综合数据库(GEO)及癌症基因组图谱(TCGA)数据库数据分析人LSCC组织中MET mRNA的表达水平;常规培养正常人支气管上皮细胞16HBE与人LSCC细胞Hep-2、KBV200和TU212,采用qPCR法和WB法检测16HBE、Hep-2、KBV200和TU212细胞中MET基因和蛋白的表达水平。用LipofectamineTM3000将MET敲减质粒(si-Met)和对照质粒(si-NC)转染至Hep-2细胞中,分为空白对照组,si-NC组和si-Met组。采用MTT法、流式细胞术、划痕愈合实验分别检测各组Hep-2细胞的增殖、迁移能力、周期分布以及对5-FU和顺铂的敏感性。结果:数据库数据分析显示LSCC组织中MET mRNA呈高表达(P<0.05),Hep-2、KBV200和TU212细胞中MET mRNA和蛋白的表达水平也均明显高于16HBE细胞(均P<0.01)。敲减MET表达后,Hep-2细胞中METmRNA及蛋白表达水平均明显降低(P<0.01或P<0.001)、细胞增殖活力显著下降(P<0.0001)、G0/G1期细胞数量明显升高(P<0.0001)、S期细胞数量明显降低(P<0.0001)。敲减MET表达后,不同浓度5-FU或顺铂对细胞增殖的抑制率均显著升高、药物半数抑制浓度(IC50)均降低(均P<0.0001),划痕愈合率明显降低、迁移能力下降(均P<0.05)。结论:MET在人LSCC组织和细胞中呈高表达,敲减MET可有效抑制Hep-2细胞中MET的表达,抑制细胞增殖、迁移能力,使其周期阻滞于G1期,增强Hep-2细胞对5-FU和顺铂的敏感性。 展开更多
关键词 喉鳞状细胞癌 间质表皮转化因子 增殖 迁移 5氟尿嘧啶 顺铂 药物敏感性
下载PDF
直接蛋白沉淀结合串联质谱法用于血浆中5-氟尿嘧啶治疗药物监测应用
15
作者 金永增 孙亮 +2 位作者 李长坤 任彪 胡艳艳 《环境化学》 CAS CSCD 北大核心 2024年第2期685-688,共4页
本文建立一种直接蛋白沉淀结合串联质谱法测定血浆中5-氟尿嘧啶浓度的方法.以0.1 mol·L^(-1)硫酸锌作为蛋白沉淀剂处理血浆样品,离心后取上清液直接测定.以5-氟尿嘧啶-^(13)C,^(15)N_(2)为内标标准品,采用Shimadzu Shim-pack GIST-... 本文建立一种直接蛋白沉淀结合串联质谱法测定血浆中5-氟尿嘧啶浓度的方法.以0.1 mol·L^(-1)硫酸锌作为蛋白沉淀剂处理血浆样品,离心后取上清液直接测定.以5-氟尿嘧啶-^(13)C,^(15)N_(2)为内标标准品,采用Shimadzu Shim-pack GIST-HP C18-AQ (100 mm×2.1mm I.D.,1.9μm)色谱柱;水(A相)-甲醇(B相)为流动相,梯度洗脱:0—1 min,5%B;1—2 min,5%B→95%B;2—2.5 min,95%B;2.5—2.6 min,95%B→5%B;2.6—5 min,5%B,流速:0.3mL·min-1;柱温:35℃;进样体积:5μL;采用电喷雾离子源,负离子多反应监测模式(MRM)进行质谱定量分析.检测离子对:5-氟尿嘧啶m/z 129.1→42.1,5-氟尿嘧啶-^(13)C,^(15)N_(2)内标标准品m/z 132.1→44.1.该方法校准曲线相关系数大于0.999.质控品测定准确度结果与理论值接近,批内及批间准确度在94.8%—99.0%之间,RSD在0.9%—4.8%之间.5-氟尿嘧啶提取回收率在95.6%—99.8%之间.基质因子在0.92—0.96之间,内标归一化的基质因子在0.99—1.00之间.稳定性各实验条件下每一测定浓度的均值与标示浓度的相对偏差RE均在-5.2%—1.7%之间.该方法前处理简便、分析速度快、灵敏度高、专属性强、稳定性好,可用于5-氟尿嘧啶治疗药物监测. 展开更多
关键词 直接蛋白沉淀 串联质谱 5-氟尿嘧啶 治疗药物监测
下载PDF
组蛋白去乙酰化酶HDAC5调控乳腺癌的研究进展
16
作者 刘承华 梅惠卿 +2 位作者 张嘉乐 李华琴 吴文梅 《激光生物学报》 CAS 2024年第2期108-114,共7页
乳腺癌是世界范围内最常见的恶性肿瘤之一,在女性群体中发病率较高。作为IIa组蛋白去乙酰化酶(HDACs),组蛋白去乙酰化酶5(HDAC5)在乳腺癌患者和健康人群中的表达存在巨大的差异,从而成为在乳腺癌乃至其他癌症中具有潜在价值的生物标志... 乳腺癌是世界范围内最常见的恶性肿瘤之一,在女性群体中发病率较高。作为IIa组蛋白去乙酰化酶(HDACs),组蛋白去乙酰化酶5(HDAC5)在乳腺癌患者和健康人群中的表达存在巨大的差异,从而成为在乳腺癌乃至其他癌症中具有潜在价值的生物标志物之一,被认为是抗癌药物的可靠分子治疗靶点。本文将对HDAC5的结构表征和其在乳腺癌发生发展中的作用,以及HDAC5抑制剂的应用作一简要总结,并为早期乳腺癌HDACs的检测、HDACs抑制剂(HDACi)的设计以及与HDACi联用的相关药物作用靶点等方面提供可行性建议,以期为乳腺癌肿瘤治疗提供理论策略参考。 展开更多
关键词 乳腺癌 组蛋白去乙酰化酶 组蛋白去乙酰化酶5 组蛋白去乙酰化酶5抑制剂 药物作用靶点
下载PDF
二烯丙基二硫增强DJ-1过表达人胃癌SGC7901细胞对5-FU的敏感性
17
作者 寻艺 夏红 +3 位作者 李志敏 刘芳 苏琦 苏波 《中国药理学通报》 CAS CSCD 北大核心 2024年第1期99-105,共7页
目的 探讨二烯丙基二硫(diallyl disulfide, DADS)是否增强DJ-1(protein/nucleic acid deglycase,蛋白/核酸去糖化酶)过表达人胃癌SGC7901细胞对5-FU(5-fluorouracil, 5-氟尿嘧啶)的敏感性。方法 实验分为Control组、DADS组、VCR(Vincri... 目的 探讨二烯丙基二硫(diallyl disulfide, DADS)是否增强DJ-1(protein/nucleic acid deglycase,蛋白/核酸去糖化酶)过表达人胃癌SGC7901细胞对5-FU(5-fluorouracil, 5-氟尿嘧啶)的敏感性。方法 实验分为Control组、DADS组、VCR(Vincristine,长春新碱)组、VCR+DADS组、DJ-1组、DJ-1+DADS组;MTT检测DADS对5-FU抑制细胞增殖的影响;流式细胞术检测DADS对细胞凋亡的影响;qRT-PCR、Western blot、免疫荧光检测DADS对耐药相关基因表达的影响。结果 DADS增强5-FU对VCR耐药细胞和DJ-1过表达细胞增殖的抑制作用;DADS诱导VCR耐药细胞凋亡;DADS下调DJ-1表达、诱导DJ-1过表达细胞凋亡;过表达DJ-1上调P-糖蛋白(P-glycoprotein, P-gp)、Bcl-2、XIAP(X连锁凋亡抑制蛋白),下调caspase-3表达;DADS降低DJ-1过表达细胞和VCR耐药细胞P-gp、Bcl-2、XIAP,升高caspase-3表达。结论 DADS能增强DJ-1过表达细胞对5-FU的敏感性,与其拮抗DJ-1介导的P-gp、Bcl-2、XIAP上调、caspase-3下调有关。 展开更多
关键词 二烯丙基二硫 DJ-1 P-糖蛋白 胃癌细胞 耐药 5-氟尿嘧啶
下载PDF
下调miR-208a通过靶向SFRP1介导Wnt信号通路对结直肠癌细胞5-FU耐药的改善作用
18
作者 胡兵兵 罗康宁 +3 位作者 彭肃 周煜中 陈茂良 刘昌化 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2024年第4期947-955,共9页
目的:探讨下调微小RNA-208a(miR-208a)对结直肠癌细胞5-氟尿嘧啶(5-FU)耐药的影响,阐明其相关分子机制。方法:采用实时荧光定量PCR(RT-qPCR)法检测结直肠癌5-FU耐药细胞株HT-29/5-FU及其亲本HT-29细胞中miR-208a和分泌型卷曲相关蛋白1(S... 目的:探讨下调微小RNA-208a(miR-208a)对结直肠癌细胞5-氟尿嘧啶(5-FU)耐药的影响,阐明其相关分子机制。方法:采用实时荧光定量PCR(RT-qPCR)法检测结直肠癌5-FU耐药细胞株HT-29/5-FU及其亲本HT-29细胞中miR-208a和分泌型卷曲相关蛋白1(SFRP1)mRNA表达水平。以HT-29/5-FU细胞为研究对象,将miR-208a抑制物(miR-208a inhibitor)质粒及其阴性对照质粒(inbibitor-NC)和SFRP1小干扰质粒(si-SFRP1)及其阴性对照质粒(si-NC)分别或同时转染至HT-29/5-FU细胞中,联合5-FU处理,将细胞分为空白组、inhibitor-NC组、miR-208a inhibitor组、miR-208a inhibitor+si-NC组和miR-208a inhibitor+si-SFRP1组。MTT法检测各组细胞增殖活性并计算耐药指数,AnnexinⅤ-FITC/PI双染法结合流式细胞术检测不同浓度5-FU作用后各组细胞凋亡率,Western blotting法检测各组细胞中SFRP1、β-连环蛋白(β-catenin)、P-糖蛋白(P-gp)和ATP结合盒B亚家族成员1转运蛋白(ABCB1)蛋白表达水平。双荧光素酶报告基因实验验证miR-208a与SFRP1的靶向关系。结果:与HT-29细胞比较,HT-29/5-FU细胞中miR-208a表达水平升高(P<0.05),SFRP1 mRNA表达水平降低(P<0.05)。与inhibitor-NC组比较,miR-208a inhibitor组细胞增殖活性降低(P<0.05),耐药指数降低,细胞凋亡率升高(P<0.05),细胞中β-catenin、P-gp和ABCB1蛋白表达水平降低(P<0.05)。双荧光素酶报告基因实验提示SFRP1是miR-208a靶基因,且miR-208a可负向调控SFRP1的表达。与miR-208a inhibitor+si-NC组比较,miR-208a inhibitor+si-SFRP1组细胞增殖活性升高(P<0.05),耐药指数升高,细胞凋亡率降低(P<0.05),细胞中β-catenin、P-gp和ABCB1蛋白表达水平升高(P<0.05)。结论:下调miR-208a可通过靶向上调SFRP1表达抑制Wnt信号通路的转导,进而改善HT-29/5-FU细胞对5-FU的耐药。 展开更多
关键词 结直肠肿瘤 微小RNA-208a 分泌型卷曲相关蛋白1 WNT信号通路 5-氟尿嘧啶 耐药性
下载PDF
5-氨基酮戊酸可溶微针的制备及评价
19
作者 李莹莹 周荣震 +3 位作者 赵治博 王帅 马涛 王清清 《牡丹江医学院学报》 2024年第5期131-135,共5页
目的制备一种性能优良的5-氨基酮戊酸(ALA)可溶微针。方法采用聚二甲基硅氧烷模具法制备ALA可溶微针,使用数码显微镜观察其形貌;通过封口膜穿刺实验、台盼蓝微针穿刺实验和在体穿刺实验评估其穿刺性能;建立HPLC法检测其载药量和体外释... 目的制备一种性能优良的5-氨基酮戊酸(ALA)可溶微针。方法采用聚二甲基硅氧烷模具法制备ALA可溶微针,使用数码显微镜观察其形貌;通过封口膜穿刺实验、台盼蓝微针穿刺实验和在体穿刺实验评估其穿刺性能;建立HPLC法检测其载药量和体外释放率。结果ALA可溶微针的针尖呈圆锥状,表面光滑且形状完整;对封口膜1~5层的穿透率分别为100%、100%、96.7%、86.7%和7.7%;台盼蓝微针在皮肤上的穿透率为100%;在皮肤内形成类圆锥形孔道;建立的检测ALA含量测定的HPLC法专属性强,精密度和准确度均符合检测要求,ALA可溶微针的平均载药量为354.10μg,6 min可完全释放。结论本研究制备了一种穿刺性能优良、载药量稳定的ALA可溶微针,并建立了适用于可溶微针载药量检测的方法。 展开更多
关键词 5-氨基酮戊酸 可溶微针 穿刺性能 载药量
下载PDF
Application and Effect Evaluation of the Integrated“5A and 3+3”Management Model in the Safe Medication Use for Chemotherapy Patients
20
作者 Li He Tingting Huo +3 位作者 Na Yao Yi Liu Yingdi Wei Yan Zhang 《Journal of Clinical and Nursing Research》 2024年第9期14-23,共10页
Objective:To explore the application and effect evaluation of the integrated“5A and 3+3”management model in ensuring safe medication use for chemotherapy patients.Methods:A total of 100 intravenous chemotherapy pati... Objective:To explore the application and effect evaluation of the integrated“5A and 3+3”management model in ensuring safe medication use for chemotherapy patients.Methods:A total of 100 intravenous chemotherapy patients admitted to the oncology department of Shaanxi Provincial People’s Hospital were randomly divided into two groups using a random number list method.Both groups received conventional nursing management during chemotherapy,while the study group additionally received the integrated“5A and 3+3”safety management model.The nursing intervention effects between the two groups were compared.Results:After the intervention,the study group showed higher levels of self-management ability,compliance,and nursing satisfaction compared to the control group.The overall incidence of adverse events during hospitalization was lower in the study group,with statistically significant differences(P<0.05).The knowledge scores of medical staff in the study group,related to the prevention and treatment of chemotherapy drug side effects,daily symptom management,and daily life management,were higher than those in the control group,with statistically significant differences(P<0.05).Conclusion:Implementing the integrated“5A and 3+3”model in the safe medication management of intravenous chemotherapy patients can effectively enhance patients’self-management abilities and compliance,improve medical staff’s ability to safely administer chemotherapy drugs,reduce adverse events caused by chemotherapy,and increase patient satisfaction. 展开更多
关键词 Intravenous chemotherapy Safe medication Adverse drug reactions 5A”management “3+3”management
下载PDF
上一页 1 2 33 下一页 到第
使用帮助 返回顶部